Chemotherapy in frail elderly patients with hormone-refractory prostate cancer: A “real world” experience

BACKGROUND: In elderly patients affected by metastatic castration-resistant prostate cancer (mCRPC) chemotherapic treatment may be the choice if one considers not only the chronological age, but also the clinical status, the functional reserve, and the vulnerability of patients. Several studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Tralongo, Paolo, Bordonaro, Sebastiano, Di Mari, Annamaria, Cappuccio, Francesco, Rametta Giuliano, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789324/
https://www.ncbi.nlm.nih.gov/pubmed/27014659
http://dx.doi.org/10.1016/j.prnil.2015.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789324/
https://www.ncbi.nlm.nih.gov/pubmed/27014659
http://dx.doi.org/10.1016/j.prnil.2015.12.003

Ejemplares similares